Neuroinflammation: The Silent Driver of Alzheimer’s Pathology

Neuroinflammation has increasingly been recognized as a major factor in Alzheimer’s disease progression. This session will explore how immune system dysfunction, particularly the role of microglia and astrocytes, contributes to neuroinflammation and the pathogenesis of dementia. It will examine how targeting neuroinflammation offers a potential therapeutic pathway for slowing or halting disease progression, with a focus on new anti-inflammatory therapies under development.
 

    Related Conference of Neuroinflammation: The Silent Driver of Alzheimer’s Pathology

    September 22-23, 2025

    6th Annual Congress on Psychiatry

    Paris, France
    October 27-28, 2025

    39th International Conference on Psychiatry and Mental Health

    Amsterdam, Netherlands
    November 10-11, 2025

    International Congress on Cognitive Psychotherapy

    Vancouver, Canada
    November 10-11, 2025

    5th Annual Psychiatrists and Psychologists Meet

    Vancouver, Canada
    November 24-25, 2025

    5thAnnual Congress on Mental Health & Psychiatry

    Barcelona, Spain
    February 16-16, 2026

    43rd Global Psychiatry and Mental Health Conference

    Paris, France
    February 16-17, 2026

    6th Annual Congress on Mental Health

    Paris, France
    April 20-21, 2026

    33rd World Psychiatrists and Psychologists Meet

    Rome, Italy
    May 27-28, 2026

    8th European Autism Congress

    Paris, France

    Neuroinflammation: The Silent Driver of Alzheimer’s Pathology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in